Familial Colorectal Cancer Risk by Subsite of Primary Cancer: a Population-based Study in Utah
Overview
Pharmacology
Authors
Affiliations
Background: Familial occurrence is common in colorectal cancer (CRC), but whether this increased familial risk differs by colonic subsite of the index patients CRC is not well understood.
Aim: To quantify the risk of CRC in first-degree (FDR), second-degree (SDR) and first cousin (FC) relatives of individuals with CRC, stratified by subsite in the colorectum and age at diagnosis.
Methods: Colorectal cancers diagnosed between 1980 and 2010 were identified from the Utah Cancer Registry and linked to pedigrees from the Utah Population Database. Age and gender-matched CRC-free controls were selected to form the comparison group for determining CRC risk in relatives using Cox regression analysis.
Results: Of the 18,208 index patients diagnosed with CRC, 6584 (36.2%) were located in the proximal colon, 5986 (32.9%) in the distal colon and 5638 (31%) in the rectum. The elevated risk of CRC in relatives was similar in analysis stratified for CRC colorectal subsites in the index cases. FDR had similarly elevated risk of all site CRC, whether the index patient had cancer in the proximal colon [hazards ratio (HR): 1.85; 95% CI: 1.70-2.02], distal colon (HR: 1.90; 95% CI: 1.73-2.08) or rectum (HR: 1.83; 95% CI: 1.66-2.02) compared to relatives of controls. This risk was consistently greater for FDR when cases developed CRC below the age of 60 years.
Conclusions: Relatives of CRC patients have a similarly elevated risk of CRC regardless of colonic tumour subsite in the index patient, and it is greatest for relatives of younger age index cases.
Tang W, Zhou L, Zhang W, Jia Y, Ge M, Hu F Tech Coloproctol. 2023; 28(1):14.
PMID: 38095784 DOI: 10.1007/s10151-023-02883-2.
Wu Y, Stump T, Hay J, Aspinwall L, Boucher K, Deboeck P Contemp Clin Trials. 2023; 131:107276.
PMID: 37393004 PMC: 10529923. DOI: 10.1016/j.cct.2023.107276.
Evidenced-Based Screening Strategies for a Positive Family History.
Kolb J, Ahnen D, Samadder N Gastrointest Endosc Clin N Am. 2020; 30(3):597-609.
PMID: 32439091 PMC: 7302941. DOI: 10.1016/j.giec.2020.02.015.
Tan K, Lopez V, Wong M, Koh G J Gastrointest Oncol. 2018; 9(3):579-588.
PMID: 29998024 PMC: 6006027. DOI: 10.21037/jgo.2018.03.02.
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.
Win A, Jenkins M, Dowty J, Antoniou A, Lee A, Giles G Cancer Epidemiol Biomarkers Prev. 2016; 26(3):404-412.
PMID: 27799157 PMC: 5336409. DOI: 10.1158/1055-9965.EPI-16-0693.